KIR3DL1 and acute myeloid leukemia: In a comprehensive comparison study of the MDS/secondary AML cohort, while other KIR-ligand models failed to demonstrate the predictive value in a multivariable analysis, a higher CF-iKIR score was associated with superior event-free survival in patients who underwent HSCT from an unrelated donor (21).